Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Research Frontiers (REFR) Cash & Equivalents (2016 - 2025)

Research Frontiers' Cash & Equivalents history spans 10 years, with the latest figure at $664299.0 for Q4 2025.

  • For Q4 2025, Cash & Equivalents changed N/A year-over-year to $664299.0; the TTM value through Dec 2025 reached $664299.0, changed N/A, while the annual FY2025 figure was $664299.0, N/A changed from the prior year.
  • Cash & Equivalents for Q4 2025 was $664299.0 at Research Frontiers, down from $1.1 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $4.8 million in Q3 2022 and bottomed at $206524.0 in Q3 2021.
  • The 5-year median for Cash & Equivalents is $1.9 million (2022), against an average of $2.1 million.
  • The largest annual shift saw Cash & Equivalents crashed 96.2% in 2021 before it soared 2223.29% in 2022.
  • A 5-year view of Cash & Equivalents shows it stood at $269964.0 in 2021, then surged by 1467.21% to $4.2 million in 2022, then tumbled by 41.48% to $2.5 million in 2023, then plummeted by 35.38% to $1.6 million in 2024, then tumbled by 58.48% to $664299.0 in 2025.
  • Per Business Quant, the three most recent readings for REFR's Cash & Equivalents are $664299.0 (Q4 2025), $1.1 million (Q3 2025), and $1.3 million (Q2 2025).